ophthalmology
Addenbrooke’s hospital offers first self-service digital eye test
July 17, 2025Research and Development Addenbrooke's Hospital, Cambridge, Opthalmology, UK, eye test, ophthalmology
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing system – DigiVis DVA system …
Merck to acquire EyeBio for an upfront $1.3bn
May 31, 2024Business Services EyeBio, Merck, Opthalmology, acquisition, ophthalmology
Merck, known as MSD outside of the US and Canada, and EyeBiotech Limited, have announced that the two companies have …
Astellas and 4D Molecular Therapeutics enter license agreement for rare ophthalmic targets
July 11, 2023Research and Development 4D Molecular Therapeutics, AAV vectors, Astellas Pharma, Opthalmology, ophthalmology
Astellas Pharma and 4D Molecular Therapeutics (4DMT) have announced a license agreement under which Astellas has the right to use …
Eyenovia announces FDA approval of first ophthalmic spray for mydriasis
May 10, 2023Research and Development Eyenovia, FDA, Opthalmology, mydriasis, ophthalmology
Ophthalmic technology company Eyenovia has announced that the US Food and Drug Administration (FDA) has approved Mydcombi (tropicamide and phenylephrine …
Astellas to acquire Ocata Therapeutics in $379m buyout
November 11, 2015Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology
Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
EM Imaging appoints new chairman
September 10, 2015Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology
The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …
Watermeadow shortlisted for medical education award
July 1, 2013Medical Communications Communique, Excellence in Ophthalmology, UK, Watermeadow Medical, award-winning agency, finalist, medical education, ophthalmology, programme
Watermeadow Medical is delighted that one of its educational programmes has been shortlisted for the ‘Excellence in Professional Education Programmes’ …
Bayer drug enters phase III for diabetic macular oedema
April 11, 2011Sales and Marketing Bayer, Lucentis, ophthalmology
Bayer and partner Regeneron have begun late stage trials for their VEGF Trap Eye candidate for diabetic macular oedema. The …
Sanofi signs ophthalmology research collaboration
March 25, 2011Research and Development Fovea, Sanofi-Aventis, Vision Institute, ophthalmology
Sanofi-Aventis has penned a collaboration with one of the main eye disease research centres in Europe. The three-year agreement between …
Novartis becomes global eye health leader as Alcon deal finalised
December 15, 2010Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology
Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
Alcon acquisition makes Novartis eyecare leader
August 26, 2010Sales and Marketing Novartis, ophthalmology
Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
Merck launches Saflutan in first European markets
September 4, 2009Research and Development, Sales and Marketing Merck, ophthalmology
Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …
Pfizer taps UCL for stem cell expertise
April 28, 2009Research and Development Pfizer, UCL, ophthalmology, regenerative medicine
Pfizer will work with researchers from University College London in the UK to try to develop stem cell-based therapies for …
Novartis and charity team up on AMD campaign
February 18, 2009Medical Communications, Sales and Marketing AMD, ophthalmology
Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …
Latest content
FibroFind appoints Lee Borthwick as CEO
